Last updated: January 6, 2025
Sponsor: University of Pittsburgh
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mycosis Fungoides
Atopic Dermatitis
Sezary Syndrome
Treatment
Blood draw, skin biopsy or urine collection
Clinical Study ID
NCT00177268
STUDY19010322
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 or older
able and willing to provide informed consent
diagnosed with CTCL
diagnosed with either atopic dermatitis or eczema
Exclusion
Exclusion Criteria:
- Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Blood draw, skin biopsy or urine collection
Phase:
Study Start date:
October 01, 2004
Estimated Completion Date:
January 31, 2032
Study Description
Connect with a study center
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania 15213
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.